Product Information

ENTECAVIR 0.5 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.2134 per EA under NDC 31722083390. Its NADAC has been published 568 times since Oct 7, 2015.

FDA first approved this application on Aug 21, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ENTECAVIR 0.5 MG TABLET

Entecavir
$0.2134per EA

Strength

.5 mg/1

NDC

31722083390

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ENTECAVIR ANHYDROUS

Approval Type

Generic (ANDA)

FDA Application

ANDA205740

FDA Approved

8/21/2015

TE Code

AB

On Market Since

8/21/2015

Pharmacological Classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Analog
Nucleoside Reverse Transcriptase Inhibitors

Price Statistics

The NADAC for ENTECAVIR 0.5 MG TABLET has been published 568 times since Oct 7, 2015, and over the history we have for it it has declined 99.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2134 per EA
All-time high$28.8886 (Oct 14, 2015)
All-time low$0.2096 (May 20, 2026)
52-week high$0.2640
52-week low$0.2096
Median price$1.1905
Average price$3.9302
Largest weekly change+48.1% (Jul 17, 2024)
Weeks tracked568
Tracking sinceOct 7, 2015

Price History

1W

+0.1%

1M

+0.1%

3M

+1.8%

6M

-9.2%

1Y

-18.7%

3Y

-52.2%

5Y

-83.4%

All

-99.3%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ENTECAVIR 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ENTECAVIR 0.5 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.2134 per EA (NDC 31722083390), effective Aug 19, 2026.

How has the price of ENTECAVIR 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ENTECAVIR 0.5 MG TABLET has declined 99.3%. It has been tracked across 568 weekly CMS publications since Oct 7, 2015.

What are the highest and lowest recorded NADAC prices for ENTECAVIR 0.5 MG TABLET?

Since Oct 7, 2015, the NADAC for ENTECAVIR 0.5 MG TABLET has ranged from a low of $0.2096 (May 20, 2026) to a high of $28.8886 (Oct 14, 2015), with a median of $1.1905 per EA.

Are there cheaper alternatives to ENTECAVIR 0.5 MG TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENTECAVIR 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ENTECAVIR 0.5 MG TABLET?

ENTECAVIR 0.5 MG TABLET (NDC 31722083390) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.